Sort
130,381 grants matching “hiv”
Immune determinants of pediatric HIV/SIV reservoir establishment and maintenance
$1,552,021Ann M Chahroudi · Emory University · P01 · FY2025 · HD
Adjuvant Development in the context of a vaccine to protect against tuberculosis
$1,551,986Nikolai Petrovsky · Vaxine Pty Ltd · N01 · FY2022 · AI
Data Science Research
$1,551,398Paul M Thompson · University Of Southern California · U54 · FY2015 · EB
Molecular Mechanisms of HIV-1 Associated Encephalopathy
$1,551,345David J Volsky · St. Luke'S-Roosevelt Inst For Hlth Scis · P01 · FY2007 · NS
Mechanisms Regulating Chronic Immune Activation in the CNS
$1,551,284Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Chronic HIV Infection and Aging in NeuroAIDS (CHAIN) Center
$1,551,110Shilpa J Buch · University Of Nebraska Medical Center · P30 · FY2017 · MH
Epidemiology and Impact of the HIV, NCD, and Urbanization Syndemic in Africa
$1,551,103Larry William Chang · Johns Hopkins University · R01 · FY2024 · HL
Human genetics of TB resistance in HIV-infected persons
$1,550,863Erwin Schurr · Mcgill University Health Ctr Res Inst · R01 · FY2020 · AI
PS10-10138, EXPANDED HIV TESTING FOR DISPROPORTIONATELY AFFECTED POPULATIONS
$1,550,803Virginia Johns · Alabama State Dept Of Public Health · U62 · FY2010 · PS
HORMONAL CONTRACEPTON & RISK OF HIV ACQUISITION
$1,550,708Morrison Charles · Family Health International · N01 · FY2010 · HD
Health and Aging in Africa: Longitudinal Studies of an INDEPTH Community
$1,550,282Lisa F Berkman · Harvard School Of Public Health · P01 · FY2021 · AG
The heterogeneous HIV expressing reservoir: dynamics, persistence mechanisms, tissue distribution, and contribution to rebound
$1,550,158Steven A Yukl · University Of California, San Francisco · P01 · FY2024 · AI
The heterogeneous HIV expressing reservoir: dynamics, persistence mechanisms, tissue distribution, and contribution to rebound
$1,550,033Steven A Yukl · University Of California, San Francisco · P01 · FY2025 · AI
Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs
$1,550,000Billy Scott · Population Services International · U2G · FY2014 · GH
RBP-J INHIBITION AS A NOVEL LATENCY REVERSAL STRATEGY FOR HIV-1-RELATED KIDNEY DISEASES
$1,550,000University Of Kansas Medical Center Research Institute, Inc. · · FY2025 · Defense Health Agency
Clinical Trials Network: The Texas Node
$1,550,000Madhukar H Trivedi · Ut Southwestern Medical Center · U10 · FY2010 · DA
The heterogeneous HIV expressing reservoir: dynamics, persistence mechanisms, tissue distribution, and contribution to rebound
$1,549,996Steven A Yukl · University Of California, San Francisco · P01 · FY2023 · AI
Scientific Administrative Core (SAC)
$1,549,968George R Seage · Harvard School Of Public Health · P01 · FY2020 · HD
UCSF-GIVI Center for AIDS research
$1,549,809University Of California San Francisco · P30 · FY2005 · AI
Active Immune Therapy and HAART for HIV-1 Infection
$1,549,799University Of Pennsylvania · P01 · FY2003 · AI
Multi-omic understanding of the transformed host T-cell response to HIV following therapeutic vaccination
$1,549,574Dennis J Hartigan-O'Connor · University Of California At Davis · P01 · FY2025 · AI
PS04-012, HIV PREVENTION PROJECTS
$1,549,573Mary Ann Ann Cooney · Nh State Dept/Hlth Statistics/Data Mgmt · U62 · FY2008 · PS
Structure-Function Studies of the HIV-1 Envelope Glycoproteins
$1,549,551Paolo Lusso · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Lifespan/Tufts/Brown Center for AIDS Research
$1,549,534Miriam Hospital · P30 · FY2003 · AI
PS10-1001, HIV PREVENTION PROJECTS
$1,549,184Loretta Emily Haddy · West Virginia State Dept Hlth/Human Rscs · U62 · FY2011 · PS